Drug
Bion 1301
Bion 1301: highest development phase Phase 1/2, developed by Chinook Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Chinook Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| BION-1301 NCT03340883 | Phase 1/2 | Multiple Myeloma |
| BION-1301 NCT05508204 | Phase 1 | Healthy Volunteer |
Latest
No recent events.
Follow Bion 1301 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.